These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29999428)

  • 1. Misconceptions and issues regarding allometric scaling during the drug development process.
    Mahmood I
    Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):843-854. PubMed ID: 29999428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theoretical versus empirical allometry: Facts behind theories and application to pharmacokinetics.
    Mahmood I
    J Pharm Sci; 2010 Jul; 99(7):2927-33. PubMed ID: 20127826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of clearance and volume of distribution in the obese from normal weight subjects: an allometric approach.
    Mahmood I
    Clin Pharmacokinet; 2012 Aug; 51(8):527-42. PubMed ID: 22671778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies in allometric scaling for predicting human drug clearance: an historical problem and reflections on what works and what does not.
    Tang H; Mayersohn M
    Curr Top Med Chem; 2011; 11(4):340-50. PubMed ID: 21320063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allometry Is a Reasonable Choice in Pediatric Drug Development.
    Liu T; Ghafoori P; Gobburu JV
    J Clin Pharmacol; 2017 Apr; 57(4):469-475. PubMed ID: 27649629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population Pharmacokinetics: Some Observations in Pediatric Modeling for Drug Clearance.
    Mahmood I; Tegenge MA
    Clin Pharmacokinet; 2017 Dec; 56(12):1567-1576. PubMed ID: 28405936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of Drug Clearance in Premature and Mature Neonates, Infants, and Children ≤2 Years of Age: A Comparison of the Predictive Performance of 4 Allometric Models.
    Mahmood I
    J Clin Pharmacol; 2016 Jun; 56(6):733-9. PubMed ID: 26437918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of human drug clearance from two species: a comparison of several allometric methods.
    Goteti K; Garner CE; Mahmood I
    J Pharm Sci; 2010 Mar; 99(3):1601-13. PubMed ID: 19827101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.
    Senarathna SM; Batty KT
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6068-78. PubMed ID: 25092696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel model for prediction of human drug clearance by allometric scaling.
    Tang H; Mayersohn M
    Drug Metab Dispos; 2005 Sep; 33(9):1297-303. PubMed ID: 15958605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Size matters in metabolic scaling: Critical role of the thermodynamic efficiency of ATP synthesis and its dependence on mitochondrial H
    Nath S
    Biosystems; 2024 Aug; 242():105255. PubMed ID: 38901165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interspecies allometric scaling. Part I: prediction of clearance in large animals.
    Mahmood I; Martinez M; Hunter RP
    J Vet Pharmacol Ther; 2006 Oct; 29(5):415-23. PubMed ID: 16958787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting oral clearance in humans: how close can we get with allometry?
    Sinha VK; De Buck SS; Fenu LA; Smit JW; Nijsen M; Gilissen RA; Van Peer A; Lavrijsen K; Mackie CE
    Clin Pharmacokinet; 2008; 47(1):35-45. PubMed ID: 18076217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of human pharmacokinetic parameters using animal data and principles of allometry. A case using bicifadine, a non-narcotic analgesic, as an example.
    Srinivas NR; Ahlawat P
    Arzneimittelforschung; 2009; 59(12):625-30. PubMed ID: 20108647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of hybrid approach based on empirical and physiological concept for predicting pharmacokinetics in humans--usefulness of exponent on prospective evaluation of predictability.
    Sayama H; Komura H; Kogayu M
    Drug Metab Dispos; 2013 Feb; 41(2):498-507. PubMed ID: 23209193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allometric exponents do not support a universal metabolic allometry.
    White CR; Cassey P; Blackburn TM
    Ecology; 2007 Feb; 88(2):315-23. PubMed ID: 17479750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physiologically Based Pharmacokinetic Modeling and Allometric Scaling in Pediatric Drug Development: Where Do We Draw the Line?
    Johnson TN; Ke AB
    J Clin Pharmacol; 2021 Jun; 61 Suppl 1():S83-S93. PubMed ID: 34185901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vertical allometry: fact or fiction?
    Mahmood I; Boxenbaum H
    Regul Toxicol Pharmacol; 2014 Apr; 68(3):468-74. PubMed ID: 24534003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Update on the Use of Allometric and Other Scaling Methods to Scale Drug Clearance in Children: Towards Decision Tables.
    van Rongen A; Krekels EH; Calvier EA; de Wildt SN; Vermeulen A; Knibbe CA
    Expert Opin Drug Metab Toxicol; 2022 Feb; 18(2):99-113. PubMed ID: 35018879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.